ADVOCACY & ISSUES
The Hidden Epidemic
UNDERSTANDING ANTIDEPRESSANT HARM
My Mission: To raise awareness, promote transparency, and help ensure every person has the information they need to make truly informed decisions about psychiatric medications.
A Public Health Crisis Hiding in Plain Sight:
A growing number of people are living with serious, life-altering neurological injuries induced by psychiatric medications.
These remain unrecognized by both the public and healthcare professionals.
Because these risks are not clearly reflected on U.S. drug labels and doctors are not taught about them, people are never given the information necessary to make a truly informed decision before starting or stopping a psychiatric medication—and they cannot consent to risks they were never told exist.
When people are harmed, their symptoms are often mistaken for a relapse of their underlying condition, a new psychiatric disorder, or dismissed altogether, leaving many without recognition, support, or appropriate care and to suffer in silence.
The Withdrawal Crisis:
No Safe Off-Ramp
There is currently no standardized, evidence-based pathway for patients to safely come off antidepressants.
Current Tapering Recommendations Can Be Too Fast
Doctors still advise patients to stop SSRIs over just 2–4 weeks. For many people (specially those who have taken antidepressants long term), this approach can be too rapid and induce severe withdrawal.
Protracted Withdrawal Injury:
Withdrawal from antidepressants can be life-altering, leading to years of agonizing and debilitating symptoms caused by a drug-induced nervous system injury.
This is not a minor or temporary “withdrawal.” Most people imagine: people lose the ability to work or care for themselves or their families, end up hospitalized, or sometimes even take their lives out of desperation for relief from the pain.
SYMPTOMS:
Protracted withdrawal injury can cause a wide range of severe, disabling, and long-lasting symptoms affecting nearly every aspect of brain and nervous system function, including cognition, emotions, sleep, sensory processing, movement, and autonomic function:
Non-stop violent inner agitation (akathisia) — an unbearable state of inner torment and restlessness that, in severe cases, can drive suicide because the suffering feels inescapable.
Intense suicidal feelings, crushing despair, and violent or homicidal thoughts that feel completely out of character.
Waves of overwhelming neurological terror, impending doom, and adrenaline surges. Many describe it as a prolonged “bad psychedelic trip” or hallucinogenic-like state unlike anything they had ever experienced.
Complete derealization and depersonalization.
Severe dysautonomia (nervous system dysfunction), causing symptoms such as burning nerve pain, “brain burning,” heart palpitations, dizziness, POTS, crushing fatigue, severe insomnia, shaking, nausea, vision changes, and widespread physical dysfunction.
Neuro-Emotions (Neurologically Driven Emotional Symptoms) — Withdrawal can produce intense emotional symptoms—including anxiety, panic, depression, irritability, emotional lability, despair, and anger—these are not typical mental health symptoms; these arise from the profound neurological and physiological disruption caused by withdrawal.
Additional symptoms may include:
Emotional
anxiety, panic, depression, emotional blunting, irritability, rage, and intrusive thoughts.
Cognitive
brain fog, memory and concentration problems, confusion, word-finding difficulties, delirium, and hallucinations.
Neurological & Physical
brain zaps, tremors, tinnitus, visual disturbances, muscle pain and weakness, gastrointestinal dysfunction, exercise intolerance, and extreme sensitivity to light, sound, touch, smell, and temperature.
THE MISDIAGNOSIS TRAP
Withdrawal is often mistaken for a relapse of an “underlying” mental health condition or a completely new psychiatric diagnosis, leading to more psychiatric prescriptions.
TRAPPED PATIENTS
Many people remain trapped on antidepressants long-term because the withdrawal becomes so agonizing that they are unable to discontinue the medication.
Not Rare
A major systematic review of the scientific literature found that:
56%
of people who stop antidepressants experience withdrawal symptoms.
Nearly half
of those experiencing withdrawal described their symptoms as severe.
The authors concluded that antidepressant withdrawal is far more common, more severe, and can last much longer than patients and doctors had been led to believe. They also found that clinical guidelines had historically underestimated both how often withdrawal occurs and how severe it can be.
This review provided strong support for what patients had been reporting for years: antidepressant withdrawal is not always “mild and short-lived.” For some it is long lasting and disabling.
When you consider that 30–44 million Americans take antidepressants — and millions have been on them long-term — even a relatively small percentage experiencing severe withdrawal translates into an enormous number of people suffering. The scale of this problem is far greater than most people realize and represents a significant public health issue.
Why So Many People Are Forced to Turn to the Internet for Help with Withdrawal
Doctors and psychiatrists receive no formal education or training in safe withdrawal from psychiatric drugs—which is why we have to turn to the internet for answers and support. Doctors are simply not educated on this.
When counted across all platforms, there are currently more than one million members across antidepressant withdrawal forums, Facebook groups, Reddit communities, and other peer-led platforms.
These online communities have become lifelines for patients, providing some of the most practical tapering guidance, educational resources on withdrawal, shared lived experience, and hope from others who have been through it.
This is not a fringe or niche issue. The sheer size of these patient-led withdrawal communities reveals a major public health and medical system failure.
Important note: For years, patients led the way in understanding antidepressant withdrawal and safe tapering through firsthand lived experience, sharing practical knowledge within online communities. Only recently has the medical profession begun to catch up with the lay expertise that has long existed within these groups.
A Safe Path Off SSRIs: Hyperbolic Tapering
To reduce the risk of severe withdrawal, antidepressants should be tapered slowly. But what does "slowly" mean in practice?
The Problem
In routine practice, what clinicians consider a "slow taper"—typically 2–6 weeks—is often much faster than what many patients can safely tolerate. For people who have taken antidepressants for years, this may substantially increase the risk of severe withdrawal and protracted withdrawal injury.
What the Evidence Suggests
Research suggests that many long-term users may need to taper over months—or, in some cases, years—rather than weeks. The best-supported approach for minimizing withdrawal risk is hyperbolic tapering: a gradual, individualized method based on how antidepressants occupy receptors in the brain.
Learn About Hyperbolic Tapering
Understand what hyperbolic tapering is, why it matters, and the evidence behind it.
Key Research
Peer-reviewed research supporting hyperbolic tapering.
Some important things to be aware of before tapering:
Withdrawal can be delayed. You may feel completely fine after stopping your medication, only to develop severe withdrawal symptoms months later.
If a withdrawal injury occurs, reinstating the medication may not reverse it. This is why tapering gradually from the very beginning is an important harm-reduction approach.
Very small doses still have powerful effects on the brain. This is why the final milligrams are often the hardest to discontinue.
There is no one-size-fits-all tapering schedule. The pace of tapering should be guided by your nervous system, how long you have been taking the medication (generally, the longer you've been on it, the slower you should go), and how your body responds/what you can tolerate. Everyone is different.
The large commercially available tablet strengths do not allow for the small, gradual dose reductions needed for safe tapering. As a result, many people need to create customized doses using liquid formulations, compounded pharmacies, or other DIY tapering methods.
Need Help With a Taper?
Practical guidance to support a taper or discuss options with your healthcare provider.
The Chemical Imbalance Myth
For decades, the public was told that depression was caused by a “chemical imbalance” or serotonin deficiency — a narrative heavily promoted by pharmaceutical companies that lacks scientific support.
THE UMBRELLA REVIEW (2022)
A landmark study led by Dr. Joanna Moncrieff found no convincing evidence that depression is caused by low serotonin activity.
EVIDENCE CALLOUT
“There isn’t an iota of direct evidence that chemical imbalances are at the root of anyone’s mental disorder.” — Dr. Steven Hyman, Former Director of the NIMH.
THE REALITY
Antidepressants are psychoactive drugs that alter brain function in complex, unknown ways; they do not “correct” a measurable deficiency like insulin for diabetes.
Mental Health Issues are Real. The Chemical Imbalance Story Is Not:
This does not mean that anxiety, depression, or other forms of mental and emotional suffering aren’t real. They absolutely are, and they can be profoundly debilitating. Nor does it mean that biology isn’t involved.
Mental health conditions are complex and arise from the interaction of many factors.
However, the evidence does not support the simple, reductionist “chemical imbalance” story we were sold that psychiatric disorders are caused by a deficiency of serotonin or another neurotransmitter that antidepressants simply “correct.”
PSSD (Post-SSRI Sexual Dysfunction)
Post-SSRI Sexual Dysfunction (PSSD) is a serious adverse effect of antidepressants in which sexual dysfunction, emotional blunting, and cognitive impairment persist long after the medication has been discontinued—and in some cases, may be permanent.
CORE SYMPTOMS
Total genital numbness, profound emotional blunting (the inability to feel joy or love), and cognitive dysfunction.
Evidence of lasting harm
A 2025 review identified objective biological abnormalities in young men with PSSD, including evidence of genital tissue scarring (fibrosis) and other measurable structural changes.
See the study here: (313) Sexual Symptoms and Biologic Pathophysiologies of Post-SSRI Sexual Dysfunction: A 15 Year Review | The Journal of Sexual Medicine | Oxford Academic
FDA Inaction
Despite substantial scientific evidence documenting PSSD, the FDA has still not updated U.S. antidepressant warning labels to include this serious and potentially permanent adverse effect.
Researchers and clinicians first petitioned the FDA in 2018 to add warnings about persistent sexual dysfunction. After years without action, a lawsuit was filed in 2024.
To this day, the FDA has not updated the labels. As a result, patients are not warned about this potentially irreversible harm before starting treatment and are left completely blindsided when it happens.
Learn more about PSSD here:
PSSD Network is a nonprofit organization dedicated to raising awareness of Post-SSRI Sexual Dysfunction (PSSD). Visit their website to learn more about the condition, current research, patient stories, advocacy efforts, and available resources.
These videos share real patient experiences and explanations of the condition:
Warning
Do not stop any psychiatric medication abruptly. Abrupt discontinuation can trigger a severe withdrawal-induced neurological injury. If you decide to stop your medication, work with a clinician who is knowledgeable about withdrawal and experienced in hyperbolic tapering to develop a personalized tapering plan that reduces the risk of harm.